MON-650 - Enhanced Efficacy of Crisugabalin 80 Mg/D in Diabetic Peripheral Neuropathic Pain Patients with BMI ≥25 Kg/M²Or Longer Disease Duration: A Post-Hoc Analysis

Abstract Poster Presenter(s)

• XW

  Xiaohong Wu, M.D., Ph.D.

  Zhejiang Provincial People’s Hospital
  Hangzhou, China (People's Republic)

Senior Author/Primary Investigator(s)

• XW

  Xiaohong Wu, M.D., Ph.D.

  Zhejiang Provincial People’s Hospital
  Hangzhou, China (People's Republic)

Co-Author(s)

• YH

  Ye Hu, M.D.

  Zhejiang Provincial People’s Hospital
  Hangzhou, China (People's Republic)
• XY

  Xiao Ye, M.D.

  Zhejiang Provincial People’s Hospital
  Hangzhou, China (People's Republic)
• YX

  Yubo Xing, M.M.

  Zhejiang Provincial People’s Hospital
  Hangzhou, China (People's Republic)
• YL

  Yaming Li, M.M.

  Haisco Pharmaceutical Group Co, Ltd.
  Chengdu, China (People's Republic)
• SY

  Shiyu Yan, Ph.D.

  Haisco Pharmaceutical Group Co, Ltd.
  Chengdu, China (People's Republic)
• WC

  Wentao Chen, Master

  Haisco Pharmaceutical Group Co, Ltd.
  Chengdu, China (People's Republic)
• QP

  Qiuyue Pan, Ph.D.

  Haisco Pharmaceutical Group Co, Ltd
  Chengdu, China (People's Republic)

Senior Author/Primary Investigator(s)

• XG

  Xiaohui Guo, M.D.

  Peking University First Hospital
  Beijing, China (People's Republic)